Multi center, open label study to evaluate the influence of pioglitazone treatment over 6 months on metabolic control in type II diabetic patients previously treated with insulin

Trial Profile

Multi center, open label study to evaluate the influence of pioglitazone treatment over 6 months on metabolic control in type II diabetic patients previously treated with insulin

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Jan 2008

At a glance

  • Drugs Glimepiride (Primary) ; Pioglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms PIOswitch
  • Most Recent Events

    • 10 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top